Genetic engineering produces bacon safe to eat for people allergic to red meat

Genetic engineering produces bacon safe to eat for people allergic to red meat
Image: LU Staff

Genetic engineering has accidentally produced a new source of food: pork that people can eat even if they are allergic to pork and other red meat. “Some people who develop a weird and terrifying allergy to red meat after a bite from a lone star tick can still eat pork from a surprising source: Genetically modified pigs created for organ transplant research,” reports the Associated Press. Scientists have also produced a genetically modified chicken whose eggs can be eaten by people who are allergic to normal chicken eggs.

As the Associated Press explains, the allergy that keeps people from eating red meat

is called alpha-gal syndrome, named for a sugar that’s present in the tissues of nearly all mammals – except for people and some of our primate cousins. It can cause a serious reaction hours after eating beef, pork or any other red meat, or certain mammalian products such as milk or gelatin.

But where does organ transplantation come in? There aren’t enough donated human organs to go around so researchers are trying to use organs from pigs instead — and that same alpha-gal sugar is a big barrier. It causes the human immune system to immediately destroy a transplanted organ from an ordinary pig. So the first gene that Revivicor inactivated as it began genetically modifying pigs for animal-to-human transplants was the one that produces alpha-gal.

While xenotransplants still are experimental, Revivicor’s ‘GalSafe’ pigs won Food and Drug Administration approval in 2020 to be used as a source of food, and a potential source for human therapeutics. The FDA determined there was no detectable level of alpha-gal across multiple generations of the pigs.”

But don’t look for this pork and bacon in your grocery store. The pork patties, ham, pork chops and bacon produced by Revivicor is given away for free to allergy patients by Revivicor. The supply isn’t big enough yet to be distributed wholesale to supermarkets or food processors.

Revivicor is a biotech company in southwestern Virginia that plans to use cloned farm animals like pigs to provide kidneys, hearts and livers to save thousands of people who need transplants.

It creates genetically modified cloned animals whose organs won’t be rejected by people’s immune systems. “Inside a brick and glass building in an office park, scientists start by using the latest genetic engineering techniques to edit the DNA in pig skin cells. Next, the scientists employ a technique similar to that used to create the first cloned mammal — Dolly the sheep — to make cloned pig embryos. (Revivicor created the world’s first cloned pigs.)”

During a visit by a reporter, “four scientists methodically remove most of the genes from hundreds of pig eggs. They do it by gingerly piercing the egg with a tiny pipette under a microscope to suction out the DNA. Later that day, the scientists inject the edited pig skin cells inside the eggs’ outer membrane. Finally, the scientists zap the combination of cells with two electric shocks to fuse the edited cells with the emptied eggs and then start cell division to create an embryo. The resulting embryos are surgically implanted into the wombs of adult female pigs. Four months later, cloned piglets are born with 10 genetic modifications designed to make sure their organs don’t grow too big, won’t cause complications like blood clots and won’t be rejected by the human immune system.”

“Every cell in the body of this animal has those same genetic modifications. And when we procure an organ from them, like every other cell, it’s carrying the desired genetic modification that will be used for organ transplant,” says Ayares. “Their hearts, their kidneys, their lungs, their livers — all have the 10 genetic modifications so that they’ll be compatible for transplant.”

Earlier, the New York Post had an interesting article about “How pigs will save thousands of human lives through organ transplants.” Right now, there are just not enough organs for all the people who need one, resulting from people dying to the lack of functioning hearts, livers, and kidneys,

“Nearly 107,000 Americans are waiting for a lifesaving organ transplant; 90,000 of them are hoping for a kidney. The demand for organs clearly exceeds the supply,” noted science writer Ronald Bailey in 2022.

Another way to make more organ transplants available would be to pay people to donate a kidney, or to give people incentives to become organ donors upon their death (such as listing themselves as future organ donors on their driver’s licenses). Similarly, ending the ban on kidney sales would save thousands of lives annually.

Back in 2011, kidney donor Alexander Berger explained why kidney sales should be legal in The New York Times. Berger was a researcher for GiveWell, a nonprofit that helps charitable donors decide where to give. Berger predicted that allowing kidney donors to be compensated would save countless lives by giving people an incentive to donate their kidneys, resulting in a vast increase in kidney donations.

Right now, people have to be unusually altruistic to donate a kidney, since you have to spend several days in the hospital to donate one, take off a lot of time from work, and run a tiny risk of death. Few people are that selfless. Allowing kidney sales would also help the poor, who currently often are unable to obtain kidneys: as Berger notes, people unable to get kidney transplants now are “disproportionately African-American and poor.” Kidney sales would also save taxpayers money, because years of dialysis is so much more expensive than a transplant, and dialysis is commonly paid for by the taxpayers through Medicaid and other government programs.

Hans Bader

Hans Bader

Hans Bader practices law in Washington, D.C. After studying economics and history at the University of Virginia and law at Harvard, he practiced civil-rights, international-trade, and constitutional law. He also once worked in the Education Department. Hans writes for CNSNews.com and has appeared on C-SPAN’s “Washington Journal.” Contact him at hfb138@yahoo.com

Comments

For your convenience, you may leave commments below using Disqus. If Disqus is not appearing for you, please disable AdBlock to leave a comment.